GenesiDol for pain in inflammatory bowel disease
Part of Digestive system clinical trials.
This study tests a treatment called GenesiDol for people with inflammatory bowel disease who also have muscle, joint, or back pain without active joint swelling. It aims to see if it can reduce pain and improve daily functioning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with inflammatory bowel disease (like Crohn's or ulcerative colitis) for at least 6 months.
- You have persistent muscle, joint, or back pain that is at least moderate in severity.
- A rheumatologist has confirmed that you do NOT have active joint inflammation, whether you have a spondyloarthritis diagnosis or not.
- You are not currently taking blood thinners or anti-seizure medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacteria in your gut that may produce chemicals linked to ongoing pain in Crohn's disease or ulcerative colitis, even when the disease itself is not very active. Researchers want to understand why some people still have moderate to severe abdominal pain even after their inflammation has calmed down.
This study tests a brain-training technique called neurofeedback to see if it can help reduce chronic pain in people with inflammatory bowel disease (IBD). If you have IBD and ongoing muscle or joint pain that isn't caused by inflammation, this trial might help you manage pain better.
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
This study looks at people with active Crohn's disease or ulcerative colitis starting a new type of medication (anti-TNF, ustekinumab, upadacitinib, or vedolizumab), as well as people without IBD having a routine colonoscopy. It aims to collect information to better understand how these treatments work.
This study looks at why some people develop long-term pain after being newly diagnosed with ulcerative colitis or Crohn’s disease. It may help researchers understand the pain process and improve future treatments.
This study tests whether a daily probiotic supplement (a beneficial bacteria) can improve the protective lining of the gut and reduce leakage in people with inflammatory bowel disease (IBD). It involves taking the supplement for a period of time and undergoing some measurements of gut health.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.